BRIEF—J&J's buy of Pfizer consumer unit a no-go, says Reuters

US healthcare giant Johnson & Johnson is out of the running to buy the consumer health business of the world’s biggest pharma company, Reuters reports.

By pulling out of the race to buy the $20 billion unit from Pfizer, J&J leaves GlaxoSmithKline and Reckitt Benckinser as the big names preparing bids, the report states.

Centrum multivitamins and Chapstick lip balm are among the products that the successful bidder will acquire.